NOT Open Access | Hydroxychloroquine in COVID-19 Therapy: Protection Versus Proarrhythmia
Reference:
J Cardiovasc Pharmacol Ther. 2020 Jul 23:1074248420935740
In recent months, the new coronavirus SARS-CoV-2 has emerged as a worldwide threat with about 4.2 million confirmed cases and almost 300 000 deaths. Its major clinical presentation is characterized by respiratory symptoms ranging from mild cough to serve pneumonia with fever and potentially even death. Until today, there is no known medication to improve clinical symptoms or even prevent or fight the infection.
